Cargando…
Visible 405 nm Violet-Blue Light Successfully Inactivates HIV-1 in Human Plasma
Despite significant advances in ensuring the safety of the blood supply, there is continued risk of transfusion transmitted infections (TTIs) from newly emerging or re-emerging infections. Globally, several pathogen reduction technologies (PRTs) for blood safety have been in development as an altern...
Autores principales: | Ragupathy, Viswanath, Haleyurgirisetty, Mohan, Dahiya, Neetu, Stewart, Caitlin, Anderson, John, MacGregor, Scott, Maclean, Michelle, Hewlett, Indira, Atreya, Chintamani |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320750/ https://www.ncbi.nlm.nih.gov/pubmed/35890023 http://dx.doi.org/10.3390/pathogens11070778 |
Ejemplares similares
-
Complete Inactivation of Blood Borne Pathogen Trypanosoma cruzi in Stored Human Platelet Concentrates and Plasma Treated With 405 nm Violet-Blue Light
por: Jankowska, Katarzyna I., et al.
Publicado: (2020) -
A New Proof of Concept in Bacterial Reduction: Antimicrobial Action of Violet-Blue Light (405 nm) in Ex Vivo Stored Plasma
por: Maclean, Michelle, et al.
Publicado: (2016) -
New Proof-of-Concept in Viral Inactivation: Virucidal Efficacy of 405 nm Light Against Feline Calicivirus as a Model for Norovirus Decontamination
por: Tomb, Rachael M., et al.
Publicado: (2016) -
Non-ionizing 405 nm Light as a Potential Bactericidal Technology for Platelet Safety: Evaluation of in vitro Bacterial Inactivation and in vivo Platelet Recovery in Severe Combined Immunodeficient Mice
por: Maclean, Michelle, et al.
Publicado: (2020) -
Inactivation of Streptomyces phage ɸC31 by 405 nm light: Requirement for exogenous photosensitizers?
por: Tomb, Rachael M, et al.
Publicado: (2014)